Please Wait
Applying Filters...
menu
    • menu
    PharmaCompass Sponsored Ads

    Virtual Booth

    Contact Supplier

    Valsynthese, part of the SSE Group, is a CDMO focused on highly energetic and highly hazardous chemistry.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2024-10-07

    Virtual Booth

    Contact Supplier

    Menu

    Balsalazide Disodium

    ACTIVE PHARMA INGREDIENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 50Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Zydus' Generic Balsalazide Disodium Receives Approval in the U.S.
    Zydus' Generic Balsalazide Disodium Receives Approval in the U.S.

    08 Jun 2023

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=217592

    FDA
    08 Jun 2023
    Share Share
    FDA Confirms Para IV Patent Litigation for Balsalazide Disodium Capsules
    FDA Confirms Para IV Patent Litigation for Balsalazide Disodium Capsules

    26 Jul 2022

    // FDA

    https://www.pharmacompass.com/pdf/news/fda-confirms-para-iv-patent-litigation-for-balsalazide-disodium-capsules-1659337269.pdf

    FDA
    26 Jul 2022
    Share Share
    Lupin gets FDA Nod to Market Ulcerative Colitis Tablets in US
    Lupin gets FDA Nod to Market Ulcerative Colitis Tablets in US

    30 Dec 2016

    // ECONOMIC TIMES

    http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/lupin-gets-fda-nod-to-market-ulcerative-colitis-tablets-in-us/articleshow/56235777.cms

    ECONOMIC TIMES
    30 Dec 2016
    Share Share
    Lupin's Generic Balsalazide Disodium Receives Approval In US
    Lupin's Generic Balsalazide Disodium Receives Approval In US

    28 Dec 2016

    // FDA

    http://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206529

    FDA
    28 Dec 2016
    Share Share